Valeant Pharmaceuticals International Inc said on Tuesday it will "improve" its $47 billion takeover offer for drugmaker Allergan Inc, a day after the U.S. company rejected the bid.Allergan shares rose 2 percent to $162.75 in pre-market trading.Canada's Valeant said it would make the change to its cash and stock offer at a May 28 webcast in which it will discuss details of its plans for Allergan's business. Valeant said it remained committed to getting the deal done but would remain "financially disciplined."Allergan, which makes the popular anti-wrinkle treatment Botox, said on Monday that Valeant's business model was unsustainable and the offer was too risky because of uncertainty about the company's long-term growth.
Allergan, Inc. is a multi-specialty health care Company focused on developing and commercializing pharmaceuticals, biologics, medical devices and over-the-counter products. Shares of AGN remained unchanged at $159.72. In the past year, the shares have traded as low as $81.33 and as high as $170.05. On average, 4030000 shares of AGN exchange hands on a given day and today's volume is recorded at 7060.
Valeant Pharmaceuticals International, Inc., formerly Biovail Corporation, is a multinational, specialty pharmaceutical company that develops, manufactures and markets a range of pharmaceutical products. Shares of VRX remained unchanged at $130.16. In the past year, the shares have traded as low as $73.25 and as high as $153.10. On average, 2719120 shares of VRX exchange hands on a given day and today's volume is recorded at 0.
Valeant Pharmaceuticals International, Inc., formerly Biovail Corporation, is a multinational, specialty pharmaceutical company that develops, manufactures and markets a range of pharmaceutical products. Shares of VRX fell by 0.69% or $-0.98/share to $141.98. In the past year, the shares have traded as low as $73.24 and as high as $170.45. On average, 386448 shares of VRX.TO exchange hands on a given day and today's volume is recorded at 282703.
Source
